ECSP10010666A - Dronedarona para la prevención de la fibrilación auricular permanente - Google Patents

Dronedarona para la prevención de la fibrilación auricular permanente

Info

Publication number
ECSP10010666A
ECSP10010666A EC2010010666A ECSP10010666A ECSP10010666A EC SP10010666 A ECSP10010666 A EC SP10010666A EC 2010010666 A EC2010010666 A EC 2010010666A EC SP10010666 A ECSP10010666 A EC SP10010666A EC SP10010666 A ECSP10010666 A EC SP10010666A
Authority
EC
Ecuador
Prior art keywords
prevention
permanent
dronedarona
fibrilation
headphone
Prior art date
Application number
EC2010010666A
Other languages
English (en)
Inventor
Christophe Gaudin
Nacera Hamdani
Davide Radzik
Eickels Martin Van
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=39731657&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ECSP10010666(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of ECSP10010666A publication Critical patent/ECSP10010666A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
    • A61K31/343—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide condensed with a carbocyclic ring, e.g. coumaran, bufuralol, befunolol, clobenfurol, amiodarone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/06—Antiarrhythmics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Furan Compounds (AREA)
  • Medicinal Preparation (AREA)

Abstract

Uso de dronedarona para la preparación de un medicamento para uso en la prevención de la fibrilación auricular permanente.
EC2010010666A 2008-06-10 2010-12-08 Dronedarona para la prevención de la fibrilación auricular permanente ECSP10010666A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6026308P 2008-06-10 2008-06-10
EP08290531A EP2133074A1 (en) 2008-06-10 2008-06-10 Use of dronedarone for the preparation of a medicament intended for the prevention of permanent atrial fibrillation

Publications (1)

Publication Number Publication Date
ECSP10010666A true ECSP10010666A (es) 2011-01-31

Family

ID=39731657

Family Applications (1)

Application Number Title Priority Date Filing Date
EC2010010666A ECSP10010666A (es) 2008-06-10 2010-12-08 Dronedarona para la prevención de la fibrilación auricular permanente

Country Status (24)

Country Link
US (1) US20110166220A1 (es)
EP (2) EP2133074A1 (es)
JP (1) JP2011522876A (es)
KR (1) KR20110026422A (es)
CN (1) CN102056603A (es)
AR (1) AR072069A1 (es)
AU (1) AU2009259009A1 (es)
CA (1) CA2727326A1 (es)
CL (1) CL2010001422A1 (es)
CO (1) CO6280479A2 (es)
CR (1) CR11829A (es)
DO (1) DOP2010000365A (es)
EA (1) EA201071378A1 (es)
EC (1) ECSP10010666A (es)
IL (1) IL209791A0 (es)
MA (1) MA32462B1 (es)
MX (1) MX2010013698A (es)
NI (1) NI201000211A (es)
PE (1) PE20110055A1 (es)
SV (1) SV2010003756A (es)
TW (1) TW201002676A (es)
UY (1) UY31886A (es)
WO (1) WO2009150535A1 (es)
ZA (1) ZA201008871B (es)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2684564A1 (en) * 2008-04-17 2014-01-15 Sanofi Use of dronedarone for the preparation of a medicament for use in the prevention of cardiovascular hospitalization or in the prevention of atrial fibrillation
FR2930149B1 (fr) * 2008-04-17 2011-02-18 Sanofi Aventis Association de dronedarone avec au moins un diuretique, son application en therapeutique
EP2116239A1 (en) * 2008-04-29 2009-11-11 Sanofi-Aventis Method for managing the risks associated with an increase in serum creatinine during dronedarone treatment
AU2014274638B2 (en) * 2009-12-21 2016-09-15 Gilead Sciences, Inc. Method of treating atrial fibrillation
TWI508726B (zh) 2009-12-21 2015-11-21 Gilead Sciences Inc 治療心房纖維性顫動之方法
EP2387996A1 (en) * 2010-05-17 2011-11-23 Sanofi Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients with permanent atrial fibrillation
EP2387997A1 (en) * 2010-05-18 2011-11-23 Sanofi Use of dronedarone for the preparation of a medicament for the prevention of cardiovascular events in patients who developed permanent atrial fibrillation throughout the period the dronedarone is administered
AR081392A1 (es) * 2010-05-13 2012-08-29 Sanofi Aventis Uso de dronedarona para la preparacion de un medicamento para la prevencion de hospitalizaciones cardiovasculares o muerte o sucesos cardiovasculares en pacientes con fibrilacion auricular permanente
US8602215B2 (en) 2010-06-30 2013-12-10 Sanofi Methods for reducing the risk of an adverse dronedarone/beta-blockers interaction in a patient suffering from atrial fibrillation
WO2012020377A1 (en) * 2010-08-11 2012-02-16 Sanofi Use of dronedarone for the preparation of a medicament for rhythm- and rate-controlling in patients with atrial fibrillation
WO2012023024A2 (en) * 2010-08-17 2012-02-23 Lupin Limited Controlled release formulations of dronedarone
EP3326616B1 (en) * 2011-06-03 2021-07-28 Signpath Pharma Inc. Liposomal mitigation of drug-induced long qt syndrome and potassium delayed-rectifier current
EP2543361A1 (en) * 2011-07-07 2013-01-09 Sanofi Sustained release pharmaceutical oral solid dosage forms of dronedarone or one of its pharmaceutically acceptable salts
FR2977495B1 (fr) * 2011-07-07 2014-03-07 Sanofi Sa Composition pharmaceutique et forme galenique solide a haute teneur en dronedarone et son procede de preparation
EP2543363A1 (en) * 2011-07-07 2013-01-09 Sanofi Sustained release pharmaceutical oral solid dosage forms of dronedarone or one of its pharmaceutically acceptable salts
EP2543362A1 (en) * 2011-07-07 2013-01-09 Sanofi Sustained release pharmaceutical oral solid dosage form of dronedarone or one of its pharmaceutically acceptable salts
WO2013024411A1 (en) 2011-08-12 2013-02-21 Lupin Limited Co-milled formulation of dronedarone
CN112336445B (zh) * 2019-12-26 2021-11-26 上海微创电生理医疗科技股份有限公司 一种消融系统及其神经探测设备

Also Published As

Publication number Publication date
UY31886A (es) 2010-01-29
KR20110026422A (ko) 2011-03-15
EP2133074A1 (en) 2009-12-16
MX2010013698A (es) 2011-02-23
CA2727326A1 (en) 2009-12-17
AU2009259009A1 (en) 2009-12-17
US20110166220A1 (en) 2011-07-07
EA201071378A1 (ru) 2011-06-30
ZA201008871B (en) 2012-02-29
JP2011522876A (ja) 2011-08-04
SV2010003756A (es) 2011-03-15
PE20110055A1 (es) 2011-02-11
NI201000211A (es) 2011-04-27
CL2010001422A1 (es) 2011-05-13
WO2009150535A8 (en) 2010-12-23
MA32462B1 (fr) 2011-07-03
IL209791A0 (en) 2011-02-28
CN102056603A (zh) 2011-05-11
CO6280479A2 (es) 2011-05-20
AR072069A1 (es) 2010-08-04
TW201002676A (en) 2010-01-16
CR11829A (es) 2011-01-11
DOP2010000365A (es) 2011-01-15
WO2009150535A1 (en) 2009-12-17
EP2300001A1 (en) 2011-03-30

Similar Documents

Publication Publication Date Title
DOP2010000365A (es) Dronedarona para la preparacion de la fibrilacion auricular permanente
BRPI0907563A2 (pt) Derivados de 4,5-di-hidro-xazol-2-il amina
BRPI0922433A2 (pt) "sincronização dos estados de apresentação entre múltiplas aplicações".
NO20083630L (no) Nye pyridinderivater
BRPI0907453A2 (pt) Compostos, uso e preparação dos mesmos
ATE555107T1 (de) 2-aza-bicyclo-ä2,2,1-üheptan-derivate
BRPI0908424A2 (pt) Registros múltiplos de ip móvel e interações pcc
ATE554604T1 (de) Verbesserter ohrhörer
EP4125244C0 (en) HASH BASED MULTIHOSTING
BR112012004335A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0718688A2 (pt) Composições de baixa irritação e métodos para preparar as mesmas.
BRPI0813981A2 (pt) agonistas sintéticos da tlr9.
ES2620754T3 (es) Uso de 5-androstano (alquil)-3,5,6-triol en la preparación de fármacos neuroprotectores
BR112012031226A2 (pt) composto, uso do composto, composição farmacêutica, e uso de composição farmacêutica
IL207372A0 (en) Phenylpyrrole derivatives, compositions comprising the same and uses thereof
TW200942530A (en) Pyridine compounds
BRPI0911772A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0915527A2 (pt) pepitídeos, composição farmacêutica e exossomos compreendendo os mesmos, métodos e usos
BRPI0916943A2 (pt) composição lubrificante, e, uso da mesma
BR112013023575A2 (pt) “derivado de octaidrotienoquinolina, composição farmacêutica compreendendo o derivado, e uso destes”
CL2010001421A1 (es) Uso de dronedarona en la preparacion de medicamentos utiles para la prevencion de fibrilacion o aleteo auricular persistentes.
BRPI0915405A2 (pt) 7-sulfanilmetil-, 7-sulfinilmetil- e 7-sulfonilmetil-indóis substituídos e uso dos mesmos
BR112012002311A2 (pt) composto, composição farmacêutica, e, uso do composto.
BRPI0814897A2 (pt) Ímãs termicamente estabilizados para uso em fundo de poço.
DK2241564T3 (da) 3,8-diaminotetrahydroquinolin-derivat